Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization

NCT06180993 is registered in ClinicalTrials.gov with Federico Martinón Torres as lead sponsor.

NCT NCT06180993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06180993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Effectiveness and Impact of Nirsevimab Administered as Routine Immunization
Lead sponsor
Federico Martinón Torres
Phase
Observational
Overall status
Recruiting
Start date
September 25, 2023
Completion date
October 31, 2026
Enrollment
42,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rsv infection